iLoF is enabling a new era of personalized, precision medicine, by providing screening and stratification tools in an affordable, fast,portable way.
To start, we are focusing our technology on the epidemic of our century: Alzheimer's disease.
Currently headquartered in Oxford, UK, with an Engineering center in Porto, Portugal and accelerated at the Oxford Foundry, we are ateam of PhDs, scientists and inventors with a vision of revolutionizing personalized medicine and making precision diagnostic tools be the norm.
We are an inexpensive,noninvasive way of stratifying patients for Alzheimer's clinical trials, crucial to enable a treatment for the disease.
We identify gold-standard proteins that are critical for the development of effective
treatments. Using a patented, portable, inexpensive photonics and AI system.
After more than +400 major trials failed, Alzheimer's trials need help. 90% of initial
enrolled patients leave trials due to invasive, inconvenient screening.
VALUE PROPOSITION - WHY CUSTOMERS CARE:
We save 40% of the total costs for screening and 70% of the time spent screening for clinical trials of Alzheimer's. By using a non-invasive test, we transform the patient experience and make trials convenient and patient-centric
We have currently secured over 2.1M £ from a consortium composed by major pharmaceutical groups and other major healthtech european stakeholders.
We have a 18+ Months runaway and are keeping key investors on the loop and looking forward to successfully raise an additional round (to
accelerate our operations with our partners)
Our Senior leadership team has the perfect mix of backgrounds and ages, composed by senior career scientists, talented inventors, experienced
consultants and award winning business managers.
Joana S. Paiva
CTO Inventor (3 patents requests),Scientist: > 30 publications,Professor in physics Photonics and AI bio-engineer
CEO Award-winning entrepreneur, business manager and engineer, founded first company at 18.
COO PhD in Pathology from Univ. Oxford and a solid grounding in the biological mechanisms underpinning the disease and biomarker discovery.
CSO Senior scientist, Profession, Innovation in Healthcare enthusiastic